Search
for

    Sort by

    Research 841–870 of 1000+

    1. Diphenylcyclopropenone-Induced Vitiligo in a Patient with Alopecia Universalis Case reports in dermatology · 2013 · 4 citations
    2. Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders American Journal of Clinical Dermatology · 2011 · 4 citations
    3. Systematic Review and Meta-analysis of the Association Between Metabolic Syndrome and Androgenetic Alopecia Acta dermato-venereologica · 2021 · 3 citations
    4. Pharmacological therapeutics in androgenetic alopecia Journal of The Korean Medical Association · 2020 · 3 citations
    5. Hair in health and disease: an introduction Wageningen Academic Publishers eBooks · 2012 · 3 citations
    6. Dermatopathology of Common Hair Problems Journal of Cutaneous Medicine and Surgery · 1999 · 3 citations
    7. Alopecia areata: trichoscopic markers in determining disease activity Journal of the Egyptian Womenʼs Dermatologic Society · 2023 · 2 citations
    8. Atomoxetine-Associated Eyebrow Alopecia in a Girl With Attention-Deficit/Hyperactivity Disorder Journal of Clinical Psychopharmacology · 2021 · 2 citations
    9. Insulin resistance in androgenetic alopecia and acne vulgaris Egyptian Journal of Dermatology and Venereology · 2019 · 2 citations
    10. Androgen Receptor Ligands: Agonists and Antagonists Elsevier eBooks · 2017 · 2 citations
    11. Hair Growth After Gefitinib Treatment Clinical Oncology · 2005 · 2 citations
    12. Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority Journal of the European Academy of Dermatology and Venereology · 2025 · 1 citations
    13. Peripheral neuropathy associated with tofacitinib use in alopecia universalis Journal of Dermatology and Dermatologic Surgery · 2022 · 1 citations
    14. Systemic Therapies for Scarring and Non-scarring Alopecia 2017 · 1 citations
    15. Compounding as a Current Therapeutic Option in Dermatology Actas Dermo-Sifiliográficas · 2013 · 1 citations
    16. Dermatological drugs, topical agents, and cosmetics Side effects of drugs annual · 2005 · 1 citations
    17. Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care Journal of Clinical Medicine · 2026
    18. Cosmetic Outcomes and Safety of Hair Transplantation and Topical Minoxidil for Temporal Triangular Alopecia: A Systematic Review Journal of Cosmetic Dermatology · 2026
    19. Prognosis of early-onset alopecia areata: An evidence-based case report Journal of General-Procedural Dermatology & Venereology Indonesia · 2026
    20. Assessment of vitamin D levels in patients with alopecia areata: a case-control study in a Tertiary Care Hospital in North India Annals of Medicine · 2026
    21. Is Trichoscopy A Reliable Method For Differantiation Of Frontal Non-Scarring Alopecias? Research Square · 2026
    22. Editorial: Exploring innovative therapies for rare inflammatory skin diseases Frontiers in Medicine · 2026
    23. Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata The Journal of Dermatology · 2026
    24. Hair Extensions: Anatomic, Biological, and Clinical Implications in Alopecia Journal of Craniofacial Surgery Open · 2026
    25. Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata Journal of Drugs in Dermatology · 2026
    26. Trichoscopic Features, Clinical Correlates, and Risk Prediction in Female Pattern Hair Loss: A Retrospective Case-Control Study Clinical Cosmetic and Investigational Dermatology · 2026
    27. Non-Scarring Alopecia in Women Presenting with Hair Loss: Clinical Features and Influencing Factors Archives of Current Medical Research · 2026
    28. Risk factors for androgenetic alopecia: a systematic review and meta-analysis BMC Public Health · 2026
    29. Light-emitting diode photobiomodulation in dermatology: From professional systems to consumer devices — mechanisms, efficacy and safety Forum Dermatologicum · 2026
    30. No elevated risk for osteoporosis or osteopenia among women with androgenetic or frontal fribrosing alopecia treated with 5-alpha reductase inhibitors: A retrospective TriNetX cohort study Journal of the American Academy of Dermatology · 2026